Form 8-K - Current report:
SEC Accession No. 0001641172-25-010330
Filing Date
2025-05-14
Accepted
2025-05-14 16:52:41
Documents
14
Period of Report
2025-05-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45582
  Complete submission text file 0001641172-25-010330.txt   270856

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bfri-20250508.xsd EX-101.SCH 3975
3 XBRL DEFINITION FILE bfri-20250508_def.xml EX-101.DEF 26989
4 XBRL LABEL FILE bfri-20250508_lab.xml EX-101.LAB 37209
5 XBRL PRESENTATION FILE bfri-20250508_pre.xml EX-101.PRE 25609
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6803
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 25946726
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)